Diarrhea and reduced levels of antiretroviral drugs: Improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil

Clinical Infectious Diseases

Volumn 38, Issue 12, 2004, Pages 1764-1770

  Bushen, Oluma Y ^a   Davenport, John A ^a   Lima, Afonso Bezerra ^d   Piscitelli, Stephen C ^b   Uzgiris, Arejas J ^c   Silva, Terezinha M J ^d   Leite, Roberio ^d   Kosek, Margaret ^a   Dillingham, Rebecca A ^a   Girao, Arlete ^d   Lima, Aldo A M ^a,b   Guerrant, Richard L ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Tibotec Virco   (United States)

^c BAYER CORPORATION   (United States)

^d FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINE; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; GLUTAMINE; GLYCINE; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PLACEBO; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW DRUG DOSE; MALE; MUTATION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; DIARRHEA; DIPEPTIDES; DRUG RESISTANCE, VIRAL; FEMALE; GLUTAMINE; HIV; HIV WASTING SYNDROME; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 2942656778     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421394     Document Type: Article

References (31)

1. Serwadda D, Mugerwa RD, Sewankambo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985; 2:849-52.
2. Malebranche R, Arnoux E, Guerin JM, et al. Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti. Lancet 1983; 2:873-8.
3. Ullrich R, Zeitz M, Heise W, L'age M, Hoffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med 1989; 111:15-21.
4. Brantley RK, Williams KR, Silva TMJ, et al. AIDS-associated diarrhea and wasting in northeast Brazil is associated with subtherapeutic plasma levels of antiretroviral medications and with both bovine and human subtypes of Cryptosporidium parvum. Braz J Infect Dis 2003; 7:16-22.
5. Kotler DP. Human immunodeficiency virus-related wasting: malabsorption syndromes. Semin Oncol 1998; 25:70-5.
6. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:239-46.
7. Weber R, Ledergerber B, Zbinden R, et al. Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Arch Intern Med 1999; 159:1473-80.
8. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr 1993; 6:1130-8.
9. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:80-5.
10. Windmueller HG, Spaeth AE. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 1974; 249:5070-9.
11. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev 1990; 48:297-309.
12. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet 1993; 341:1363-5.
13. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: a randomized, double-blind, controlled study. Ann Intern Med 1992; 116:821-8.
14. Carneiro-Filho BA, Bushen OY, Brito GA, Lima AA, Guerrant RL. Glutamine analogues as adjunctive therapy for infectious diarrhea. Curr Infect Dis Rep 2003; 5:114-9.
15. Guerrant RL, Kosek M, Moore S, Lorntz B, Brantley R, Lima AAM. Magnitude and impact of diarrheal diseases. Arch Med Res 2002; 33: 351-5.
16. Blikslager A, Hunt E, Guerrant R, Rhoads M, Argenzio R. Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G645-53.
17. Lima AA, Carvalho GH, Figueiredo AA, et al. Effects of an alanyl-glutamine-based oral rehydration and nutrition therapy solution on electrolyte and water absorption in a rat model of secretory diarrhea induced by cholera toxin. Nutrition 2002; 18:458-62.
18. Lima AA, Soares AM, Freire Junior JE, Guerrant RL. Cotransport of sodium with glutamine, alanine and glucose in the isolated rabbit ileal mucosa. Braz J Med Biol Res 1992; 25:637-40.
19. Vesikari T, Isolauri E. Glycine supplemented oral rehydration solutions for diarrhoea. Arch Dis Child 1986; 61:372-6.
20. Lima AA, Silva TM, Gifoni AM, et al. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil. Am J Gastroenterol 1997; 92:1861-6.
21. D'Aquila R, Schapiro J, Brun-Vezinet F, et al. Drug resistance mutations in HIV-1. Top HIV Med 2002; 10:21-5.
22. Elia C, Fogaca HS, de Souza HS, et al. Clinical patterns of diarrhea in AIDS: a retrospective study at the Federal University Hospital, Rio de Janeiro. Arq Gastroenterol 1998; 35:95-9.
23. Moreira Junior ED, Silva N, Brites C, et al. Characteristics of the acquired immunodeficiency syndrome in Brazil. Am J Trop Med Hyg 1993; 48:687-92.
24. Tepper RE, Simon D, Brandt LJ, Nutovits R, Lee MJ. Intestinal permeability in patients infected with the human immunodeficiency virus. Am J Gastroenterol 1994; 89:878-82.
25. Yoshida S, Matsui M, Shirouzu Y, Fujita H, Yamana H, Shirouzu K. Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 1998; 227:485-91.
26. Tremel H, Kienle B, Weilemann LS, Stehle P, Furst P. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994; 107:1595-601.
27. Ribeiro Junior H, Ribeiro T, Mattos A, et al. Treatment of acute diarrhea with oral rehydration solutions containing glutamine. J Am Coll Nutr 1994; 13:251-5.
28. Fletcher CV, Acosta EP, Henry K, et al. Concentration-controlled zidovudine therapy. Clin Pharmacol Ther 1998; 64:331-8.
29. Kakuda TN, Page LM, Anderson PL, et al. Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir. Antimicrob Agents Chemother 2001; 45:236-42.
30. Fletcher CV, Anderson PL, Kakuda TN, et al. Concentration-controlled compared with conventional antiretroviral therapy for HIV infection. AIDS 2002; 16:551-60.
31. Noyer CM, Simon D, Borczuk A, Brandt LJ, Lee MJ, Nehra V. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. Am J Gastroenterol 1998; 93:972-5.